pirfenidone 267 MG Oral Tablet [Esbriet]

RxCUI: 1868016
RxNorm name: pirfenidone 267 MG Oral Tablet [Esbriet]
Display name: pirfenidone 267 MG Oral Tablet [Esbriet]
Full name: pirfenidone 267 MG Oral Tablet [Esbriet]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ESBRIET	PIRFENIDONE	Genentech, Inc.	2e8c3537-36d7-4de5-9b5c-7a624b9a9e6e	2025-12-05	Warnings, Adverse reactions	Exact identifier rxcui: 1868016
ESBRIET	PIRFENIDONE	Legacy Pharma USA Inc.	81f17f7d-cb04-4052-8682-dd3e330210ab	2025-06-09	Warnings, Adverse reactions	Exact identifier rxcui: 1868016

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2e8c3537-36d7-4de5-9b5c-7a624b9a9e6e	Esbriet 267 MG Oral Tablet [PSN] · pirfenidone 267 MG Oral Tablet [Esbriet] [SBD] · Esbriet 267 MG Oral Tablet [SY]	3	21	These highlights do not include all the information needed to use ESBRIET safely and effectively. See full prescribing information for ESBRIET. ESBRIET ® (pirfenidone) capsules and film-coated tablets, for oral use Initial U.S. Approval: 2014	20251205
81f17f7d-cb04-4052-8682-dd3e330210ab	Esbriet 267 MG Oral Tablet [PSN] · pirfenidone 267 MG Oral Tablet [Esbriet] [SBD] · Esbriet 267 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use ESBRIET safely and effectively. See full prescribing information for ESBRIET. ESBRIET ® (pirfenidone) capsules and film-coated tablets, for oral use Initial U.S. Approval: 2014	20250609